{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:27:14Z","timestamp":1791084434471,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":5114,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1046\/j.0022-202x.2001.01605.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:00:33Z","timestamp":1047448833000},"page":"1464-1470","source":"Crossref","is-referenced-by-count":99,"title":["Direct Evidence to Support the Role of Antigen-Specific CD8+ T Cells in Melanoma-Associated Vitiligo"],"prefix":"10.1016","volume":"117","author":[{"given":"Fr\u00e9d\u00e9rique-Anne","family":"Le Gal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Deschemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Andrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-G\u00e9rard","family":"Guillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Fran\u00e7oise","family":"Avril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Bosq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin-Xavier","family":"Dore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0010","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.1711700209","article-title":"An imunohistological study of cutaneous lymphocytes in vitiligo","volume":"170","author":"Badri","year":"1993","journal-title":"J Pathol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1046\/j.1365-2249.1996.d01-727.x","article-title":"Tyrosinase as an autoantigen in patients with vitiligo","volume":"105","author":"Baharav","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0020","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1523-1747.1999.00805.x","article-title":"Accumulation of identical T cells in melanoma and vitiligo-like leukoderma","volume":"113","author":"Becker","year":"1999","journal-title":"J Invert Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0167-5699(97)01211-5","article-title":"CD4+ T-cell memory, CD45R subsets and the persistence of antigen \u2013 a unifying concept","volume":"19","author":"Bell","year":"1998","journal-title":"Immunol Today"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0030","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/eji.1830260135","article-title":"A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes","volume":"26","author":"Brichard","year":"1996","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0035","first-page":"522","article-title":"Vitiligo-like lesions in patients with melanoma treated with immunotherapy","volume":"7","author":"Buendia-Eisman","year":"1997","journal-title":"Eur J Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0040","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/archderm.1987.01660320095019","article-title":"Prognostic significance of hypopigmentation in malignant melanoma","volume":"123","author":"Bystryn","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0045","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1084\/jem.181.1.363","article-title":"Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes","volume":"181","author":"Castelli","year":"1995","journal-title":"J Exp Med"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0050","first-page":"156","article-title":"Single-step method of RNA isolation by acid guanidinium thicyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynsky","year":"1987","journal-title":"Anal Biochem"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0055","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archderm.1995.01690150078015","article-title":"Melanoma and vitiligo are associated with antibody responses to similar antigens on pigment cells","volume":"131","author":"Cui","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/1523-1747.ep12555773","article-title":"Identification of pigment cell antigens defined by vitiligo antibodies","volume":"98","author":"Cui","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0065","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1084\/jem.180.3.1171","article-title":"An invariant V\u03b124-J\u03b1Q\/V\u03b211 T cell receptor is expressed in all individuals by clonally expanded CD4-8-T cells","volume":"180","author":"Dellabona","year":"1994","journal-title":"J Exp Med"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0070","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/intimm\/9.8.1073","article-title":"TCR analysis reveals significant repertoire selection during in vitro lymphocyte culture","volume":"9","author":"Dietrich","year":"1997","journal-title":"Int Immunol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2230.1991.tb00383.x","article-title":"Prolonged survival in metastatic malignant melanoma associated with vitiligo","volume":"16","author":"Duhra","year":"1991","journal-title":"Clin Exp dermatol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0080","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/eji.1830231103","article-title":"Number of interleukin-4- and interferon-gamma-secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation","volume":"23","author":"el Ghazali","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0085","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/40166","article-title":"Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells","volume":"389","author":"Fuhlbrigge","year":"1997","journal-title":"Nature"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0090","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4049\/jimmunol.155.3.1343","article-title":"Identification of a tyrosinase epitope recognized by HLA-A24-restricted, tumor infiltrating lymphocytes","volume":"155","author":"Kang","year":"1995","journal-title":"J Immunol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0095","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/(SICI)1097-0215(19981109)78:4<518::AID-IJC20>3.0.CO;2-0","article-title":"identification of gp100-derived, melanoma-specific cytotoxic T-lymphocyte epitopes restricted by HLA-A3 supertype molecules by primary in vitro immunization with peptide-pulsed dendritic cells","volume":"78","author":"Kawashima","year":"1998","journal-title":"International J Cancer"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0100","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.4049\/jimmunol.160.5.2099","article-title":"Human melanoma patients recognize an HLA-A1-restricted CTL epitope from tyrosinase containing two cysteine residues: implication for tumor vacine development","volume":"160","author":"Kittlesen","year":"1998","journal-title":"J Immunol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0105","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0190-9622(96)90707-0","article-title":"More on cutaneous reactions to recombinant cytokine therapy","volume":"35","author":"Le Gal","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0110","first-page":"1219","article-title":"Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance","volume":"148","author":"Le Poole","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00002030-199902040-00006","article-title":"Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly reactive antiretroviral therapy","volume":"13","author":"Martinon","year":"1999","journal-title":"AIDS"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s002620050286","article-title":"Anti-tyrosinase antibodies in malignant melanoma","volume":"42","author":"Merimski","year":"1996","journal-title":"Cancer Immunol Immunother"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0125","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1084\/jem.158.1.246","article-title":"Antibodies to normal human melanocytes in vitiligo","volume":"158","author":"Naughton","year":"1983","journal-title":"J Exp Med"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0130","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0140-6736(00)02120-6","article-title":"Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma","volume":"355","author":"Neumeister","year":"2000","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0135","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1001\/archderm.1982.01650130009007","article-title":"Vitiligo: it is important","volume":"118","author":"Nordlund","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0140","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0190-9622(83)70182-9","article-title":"Vitiligo in patients with metastatic melanoma: a good prognostic sign","volume":"9","author":"Nordlund","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0145","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.188.6.1203","article-title":"High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo","volume":"188","author":"Ogg","year":"1998","journal-title":"J Exp Med"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0150","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.4049\/jimmunol.157.6.2539","article-title":"Improved induction of melanoma-reactive CTL with peptides from the melanoma-antigen gp100 modified at HLA*0201-binding sites","volume":"157","author":"Parkhurst","year":"1996","journal-title":"J Immunol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0155","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.4049\/jimmunol.164.3.1148","article-title":"Cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression","volume":"164","author":"Pittet","year":"2000","journal-title":"J Immunol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0160","first-page":"7634","article-title":"Ex vivo IFN-\u03b3 secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases","volume":"166","author":"Pittet","year":"2001","journal-title":"J Exp Med"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0165","doi-asserted-by":"crossref","first-page":"8046","DOI":"10.1128\/JVI.69.12.8046-8050.1995","article-title":"Preferentiel usage of the T-cell repertoire by influenza virus hemaglutinin-specific human specific CD4+ T lymphocytes: in vitro life span of clonotypic cells","volume":"69","author":"Prevost-Blondel","year":"1995","journal-title":"J Virol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0170","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002371-199601000-00009","article-title":"Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy","volume":"19","author":"Rosenberg","year":"1996","journal-title":"J Immunother Emphasis Tumor Immunol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0175","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1084\/jem.183.2.527","article-title":"An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins","volume":"183","author":"Skipper","year":"1996","journal-title":"J Exp Med"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0180","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.4049\/jimmunol.157.11.5027","article-title":"Shared epitopes for HLA-A3-restricted melanoma-reactive human CTL include a naturally processed epitope from pMel-17\/gp100","volume":"157","author":"Skipper","year":"1996","journal-title":"J Immunol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0185","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(94)91709-4","article-title":"The role of tyrosinase in autoimmune vitiligo","volume":"344","author":"Song","year":"1994","journal-title":"Lancet"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0190","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.4049\/jimmunol.160.4.1750","article-title":"Enhanced generation of specific tumor-reactive CTL in vitro by selected melan-A\/MART-1 immunodominant peptide analogues","volume":"160","author":"Valmori","year":"1998","journal-title":"J Immunol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0195","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/eji.1830240340","article-title":"Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes","volume":"24","author":"W\u00f6lfel","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1046\/j.0022-202x.2001.01605.x_bb0200","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.192.11.1637","article-title":"Melanocyte destruction after immunotherapy of melanoma: direct evidence of T-cell-mediated vitiligo","volume":"192","author":"Yee","year":"2000","journal-title":"J Exp Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15414848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15414848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T02:48:21Z","timestamp":1682131701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15414848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S0022202X15414848"],"URL":"https:\/\/doi.org\/10.1046\/j.0022-202x.2001.01605.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}